Was going through the Q1 results, concall, management commentary etc iro two neglected stocks ( IMHO ) – Emami Ltd and Amrutanjan Healthcare Ltd
I think, both can potentially do well this year. However, I can’t be sure. It’s just a feel that u get going through Q1 results
Some triggers lined up for Emami Ltd –
Pickup in sales of male grooming segment and positive guidance for the rest of the year
Good strength in the sales of Zandu’s Ayurvedic products
Company posting descent results despite a weak summer season and hence weakish sales performance from Navratna franchise
Promoters pledge likely to come down from 33 pc to 18 pc post the sale of the Hospitals business to Manipal group
Kesh King Amortisation being out of the P&L for this FY
Some triggers for Amrutanjan –
Heavy channel inventory of Balms which affected the performance in FY 23 is a thing of the past now
Continued descent to good performance from Comfy ( clocking sales of around 80 cr – yearly run rate ), Fruitik and Electroplus brands ( combined sales of around 60 cr – yearly run rate ). If the company can sustain the growth in these 3 brands and go steady on the pain management category, the stock may see some potential upside
Disc: I am biased. These r just my thoughts. Can go wrong. Likely to initiate a tracking position
| Subscribe To Our Free Newsletter |
